Michał Kunc

Tumor-Infiltrating Lymphocytes (TILs) in Breast Cancer: Prognostic and Predictive Significance across Molecular Subtypes

Aleksandra Ciarka, Michał Piątek, Rafał Pęksa et al. · Biomedicines · 2024 · 60 citations · Full text

Medicine, Immunology, Oncology +17

Frequent expression of somatostatin receptor 2a in olfactory neuroblastomas: a new and distinctive feature

Piotr Czapiewski, Michał Kunc, Adam Gorczyński et al. · Human Pathology · 2018 · 33 citations · Full text

Life Sciences, Molecular Biology, Oncology +9

MAML2 rearrangement as a useful diagnostic marker discriminating between Warthin tumour and Warthin-like mucoepidermoid carcinoma

Michał Bieńkowski, Michał Kunc, Mariola Iliszko et al. · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 2020 · 25 citations · Full text

Dentistry, Oncology, Oral Pathology +17

High PD-L1 Expression on Tumor Cells Indicates Worse Overall Survival in Advanced Oral Squamous Cell Carcinomas of the Tongue and the Floor of the Mouth but Not in Other Oral Compartments

Łukasz Adamski, Anna Starzyńska, Paulina Adamska et al. · Biomedicines · 2021 · 20 citations · Full text

Medicine, Immunology, Oncology +17

Immune checkpoint receptor VISTA on immune cells is associated with expression of T-cell exhaustion marker TOX and worse prognosis in renal cell carcinoma with venous tumor thrombus

Łukasz Zapała, Michał Kunc, Sumit Sharma et al. · Journal of Cancer Research and Clinical Oncology · 2022 · 18 citations · Full text

Medicine, Immunology, Oncology +17